Article metrics
PDFThursday 06 October 2022 from 13:00 to 14:10
PO.4 E- POSTER SESSION 4: disease activity measurements, flare and remission, epidemiology, etiology, genetics, epigenetics
PO.4.75 The anti-BDCA2 antibody biib059 improves joint and skin manifestations in patients with SLE and both active arthritis and rash
